Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
MP Healthcare Venture Management
AddedFeb 15, 2024
UpdatedJun 28, 2026
MP Healthcare Venture Management

MP Healthcare Venture Management

Operating

MP Healthcare Venture Management: A US-based venture capital firm investing in biotech and healthcare sectors.

Location
Boston, MA, US
Founded
2006
Firm
Compare
Portfolio
Employees
Website

MP Healthcare Venture Management is a Boston-based life science venture capital firm focused on investing in biotechnology, therapeutics, diagnostics, and vaccine companies. The firm primarily targets early to mid-stage investments, with a concentration on Seed, Series A, and Series B rounds in the United States healthcare sector.

The firm collaborates closely with healthcare entrepreneurs to develop novel technologies and therapeutics. Notable portfolio companies include Genocea Biosciences, Korro Bio, QurAlis, and Ribometrix. MP Healthcare Venture Management is recognized for its early support and transformative impact on portfolio companies, offering valuable partnerships and integral support to foster innovation in the life sciences industry.

MP Healthcare Venture Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments14
Current Portfolio Count4
Total Portfolio Exits1

Top Investment Stages

Series B5 (35.7%)
Series A4 (28.6%)
Seed3 (21.4%)
Series C1 (7.1%)
Series Unknown1 (7.1%)

Stage Mix

Series B 36%Series A 29%Seed 21%Series C 7%Series Unknown 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

QurAlis logo

QurAlis

Korro Bio logo

Korro Bio

Ribometrix logo

Ribometrix

Sonde Health logo

Sonde Health

Genocea Biosciences logo

Genocea Biosciences

Syndexa Pharmaceuticals logo

Syndexa Pharmaceuticals

Similar Investment Firms

MPM Capital logo

MPM Capital

mpmbioimpact.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Mass Medical Angels logo

Mass Medical Angels

massmedangels.com

BioImpact Capital logo

BioImpact Capital

Mediphase Venture Partners logo

Mediphase Venture Partners

Bioventures Investors logo

Bioventures Investors

Mass General Brigham Ventures logo

Mass General Brigham Ventures

Boston Medical Investors logo

Boston Medical Investors

MedScience Ventures logo

MedScience Ventures

McKesson Ventures logo

McKesson Ventures

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Qiming Venture Partners USA logo

Qiming Venture Partners USA

qimingvcusa.com

Optum Ventures logo

Optum Ventures

optumventures.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

MP Healthcare Venture Management - Classification

Also Known As
  • MP Healthcare Venture Management Inc
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end